PatrickJLeaveyMD
Pediatric Hematology & Oncology • Dallas, TXProfessor of Pediatrics, University of Texas Southwestern Medical Center, Southwestern Medical School
Dr. Leavey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-456-2382Fax+1 214-456-6133- Is this information wrong?
Education & Training
University of ColoradoResidency, Pediatrics, 1996 - 1999- University of ColoradoFellowship, Pediatric Hematology/Oncology, 1992 - 1995
Royal College of Surgeons IrelandClass of 1986
Certifications & Licensure
TX State Medical License 1998 - 2024
CO State Medical License 1995 - 2001- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma Start of enrollment: 2010 Nov 22
- Phase 2 Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma Start of enrollment: 2012 Aug 01
- Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma Start of enrollment: 2019 Oct 03
Roles: Principal Investigator, Contact
- Join now to see all
Publications & Presentations
PubMed
- Osteosarcoma Explorer: A Data Commons With Clinical, Genomic, Protein, and Tissue Imaging Data for Osteosarcoma Research.Donghan M Yang, Qinbo Zhou, Lauren Furman-Cline, Xian Cheng, Danni Luo, Hongyin Lai, Yueqi Li, Kevin W Jin, Bo Yao, Patrick J Leavey, Dinesh Rakheja, Tammy Lo, David H...> ;JCO Clinical Cancer Informatics. 2023 Sep 1
- 17 citationsAn international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma.Shulman, D., Whittle, S., Surdez, D., Bailey, K., de Álava, E., Yustein, J., Shlien, A., Hayashi, M., Bishop, A., Crompton, B., DuBois, S., Shukla, N., Leavey, P., Les...> ;NPJ Precision Oncology. 2022 Sep 17
- 2 citationsEnhancing access to and diversity in cancer clinical trials through a financial reimbursement program: Protocol to evaluate a novel program.Jasmin A Tiro, Lorna H McNeill, Erin L Williams, Hong Zhu, Simon J Craddock Lee, Patrick J Leavey, Navid Sadeghi, Kandice A Kapinos, Dana L Dornsife, Vivian Nguyen, E ...> ;Contemporary Clinical Trials. 2022 Oct 1
- Join now to see all
Press Mentions
Vignettes of Vermonters Adapting to Life in a PandemicMarch 25th, 2020- Developing a Top-Tier Pediatric Experimental Therapeutics ProgramOctober 10th, 2016
Developing a Top-Tier Pediatric Experimental Therapeutics ProgramOctober 7th, 2016
Grant Support
- Metabolic Profiling in Pediatric Fusion Positive SarcomaNIH-NCI Center for Cancer Research2018–2020
- Using imaging and computational tools to improve risk stratification in children with bone cancerCancer Prevention and Research Institute of Texas (CPRIT)2015–2019
Professional Memberships
- Fellow
- American Society of Pediatric Hematology/OncologyPresident
Hospital Affiliations
University of Texas Southwestern Medical CenterDallas, Texas
Children's Medical Center DallasDallas, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
